Brian L. Wilson
View Brian L. Wilson's Articles BY TICKER:
AAPL,
ABIO,
ABT,
ACAD,
ACHN,
ACRX,
AEGR,
AEZS,
AFFY,
ALXA,
AMPE,
AMRN,
AMZN,
ANAC,
ANTH,
APPA.OB,
APPY,
ARAY,
ARIA,
ARNA,
ARQL,
ARRY,
ASTX,
ATHX,
ATRS,
AVEO,
BAC,
BBRY,
BCRX,
BHP,
BIIB,
BLRX,
BMRN,
C,
CBMX,
CELG,
CHTP,
CLDX,
CLSN,
CLVS,
CORT,
CPRX,
CRME,
CUR,
CVM,
CYCC,
CYNO,
CYTK,
DARA,
DCTH,
DIS,
DMPI.OB,
DNDN,
DSCO,
DVAX,
EDAP,
EXEL,
F,
FOLD,
FRX,
FURX,
GALT,
GE,
GSK,
GWAY,
HALO,
HPTX,
HZNP,
IBM,
IMGN,
INO,
INTC,
ISIS,
ITMN,
JNJ,
JPM,
KERX,
KO,
LLY,
LNG,
LON,
LPTN,
LXRX,
MAKO,
MDVN,
MNKD,
MRK,
MSLP.OB,
MYRX,
NAVB,
NPSP,
NSPH,
NVS,
NWBO,
OMER,
ONCY,
ONXX,
OPK,
OPXA,
ORCL,
OREX,
OSIR,
OSUR,
OXY,
PCRX,
PCYC,
PFE,
PGNX,
PPHM,
PTN,
QCOR,
REGN,
RIGL,
RMTI,
RPRX,
RPTP,
SCMP,
SDRL,
SGMO,
SKUL,
SLV,
SNGX.OB,
SPPI,
SPY,
SRPT,
STML,
STXS,
SUPN,
T,
THRX,
TKMR,
TLON.OB,
TTNP.OB,
VRTX,
VVUS,
WMT,
ZGNX,
ZIOP
- Watch Achillion Pharmaceuticals For Upcoming Phase IIa Data
- Omeros Corporation Continues To Look Strong
- There's No Shortage Of Factors Hurting Shares Of Oracle
- Why Pfizer Is One Of The Best Defensive Plays On The Market Today
- Cel-Sci Offers Huge Potential Gains With Revolutionary Immunotherapy Anti-Cancer Drug
- Still Betting On Chelsea's Flagship Drug?
- New Data On Loncor's Prospects Point To Share Appreciation
- The Compelling Investment Case For Deep-Water Drilling
- Catalysts On Tap For Corcept Therapeutics
- Will Cost Cuts Bring High Dividends Back To Citi And Other Financials?
- Pfizer: Why It's All In The Pipeline
- Jumping The Gun On Bank Of America
- Expecting Catalyst Action For Astex Pharmaceuticals
- Heavy Activity For Furiex Pharmaceuticals In 2012
- 2 Pharmaceutical Stocks Ready To Move
- When Is The Right Time For Financial Stocks?
- Loncor: A Junior Gold Miner Poised For Huge Gains
- Pfizer In A Post-Lipitor World: Worth Buying On Dips
- How Oracle May Evolve Into A Value Stock In 2012
- One Amazing Pharmaceutical Stock To Watch In 2012
- Don't Hold Your Breath For BofA Shares To Spike
- 3 Reasons To Hold Off On Apple For Now
- Mainstream Dividend Stocks And Their Higher-Yield Alternatives
- How Bad Is Wall Street's Italian Debt Exposure?
- 3 Events That Should Set Us Up For Market's Next Big Move
- Time To Take A Warren Buffett Approach
- Is Wal-Mart A Buy?
- Amarin Stabilizes Ahead Of FDA Decision
- Greenback Momentum Vs. The Economy: How Will It Play Out?
-
The 3 Biggest Reasons To Stay Out Of Bank Stocks
- 4 Dividend Stocks To Buy If The Market Tanks
- Investing In Eurozone Weakness: Italy Could Be Worse Than Greece